France · Series D startup

Who invested in Spine Next

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$14Mraised across 2 rounds since 2000, from 2 sources

$12MSeries A$2.0MSeries D
Latest round
Series D, $2.0MMar 2004
Biggest round
$12MSeries A · Feb 2000
Investors
2
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20002001200220032004
$12MSeries A$2.0MSeries D
First round
Series A, $12M
Feb 2000
Biggest round
$12M
Series A · Feb 2000
Between rounds
4.1 years
from the last two

The rounds

  1. Mar 2004
    Series D$2.0M1 new

    From a historical funding record

  2. Feb 2000
    Series A$12M1 new

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

The exit

ExitBuyerPriceWhen
AcquiredAbbott LabsundisclosedOct 2004

From historical deal records. Wrong? Tell us.

Everyone who backed them

Auriga PartnersVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Spine Next

Who invested in Spine Next?

Spine Next's investors include Auriga Partners and Viscogliosi Bros., LLC.

How much has Spine Next raised?

Spine Next has raised $14M across 2 rounds since 2000.

When did Spine Next last raise?

Spine Next's most recent round was a Series D of $2.0M in Mar 2004.

What was Spine Next's biggest round?

Spine Next's largest round on record is $12M (Series A), in Feb 2000.

Who backed Spine Next first?

Spine Next's first round on record, in Feb 2000, was backed by Auriga Partners.

What stage is Spine Next at?

Spine Next's latest named round is a Series D, in Mar 2004.

Where is Spine Next based?

Spine Next is based in France.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.